electroCore Announces First Quarter Financial Results
May 14, 2020 16:05 ET
|
electroCore
Generated first quarter revenue of $734,000 Secured FDA clearance of gammaCore™ (nVNS) label expansion for migraine prevention Announced initiatives to support the potential use of nVNS for the...
electroCore to Announce First Quarter Ended March 31, 2020 Financial Results on Thursday, May 14
May 07, 2020 08:00 ET
|
electroCore
BASKING RIDGE, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the...